The multi-million-dollar collaboration between Novo Nordisk and US-based Dicerna, dealing with the development of new potential RNA drugs, has seen its second candidate, the former tells MedWatch.
According to the pharmaceutical companies, the selection occured in the first half of the year, meaning that so far, the partnership, which was announced in 2019, has resulted in two preclinical candidates for futher developement. Both are within cardiometabolic diseases, which is all Novo Nordisk is prepared to say.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Carb-X secures USD 370m in fight against antibiotic resistance
International antibiotic alliance Carb-X has received commitments of up to USD 370m to accelerate the development of new antibiotics to combat a future shortage. The news is welcomed by several players on the AMR field.
Former Ambu CEO's equity investments end in USD 2m losses
Juan Jose Gonzalez, who was the CEO of medtech firm Ambu until very recently, has lost just over DKK 16m (USD 2.3m) before taxes on his share purchases.
Jesper Høiland retires as chief commercial officer of Ascendis Pharma
Former executive vice president of Novo Nordisk, US, Jesper Høiland has decided to step down from his role as global chief commercial officer at Ascendis Pharma.
ALK finds replacement for long-time North America lead
Jorge Alderete, ALK’s president in North America, is leaving the firm after 23 years. He will be replaced by Hans Lindeberg, ALK’s current head of the Nordic region.
Monkeypox vaccine attracts interest for Bavarian as virus spreads
Bavarian, which signed a supply contract with an unnamed European country last week, reports it is in dialog with several countries, some yet to be affected, concerning the firm’s monkeypox vaccine.
Nordic Medical Affairs Manager 
Laboratory technician for process development and clinical manufacturing 
(Senior) Drug Substance Specialist 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Biostatistician 
Clinical Project Manager 
Cell Culture Scientist/Senior Scientist 
IRT Manager, Clinical Drug Supply 
Account Manager 
Director for innovative pre-clinical testing unit 
Innovation Project Manager, Display Unit 
Communications Consultant 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Production Director 
2 Sales Representatives and Product Specialists 
Client Talent Acquisition Specialist 
Director Global Engineering 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Senior Chemical Safety Advisor